Intravitreal Bevacizumab for the treatment of Myopic choroidal neovascularisation in an Asian population

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 6, 2010, Pages 493-494

  Loh, Boon Kwang ^a   Lee, Shu Yen ^a   Cheng, Jacob ^a   Yeo, Ian ^a   Wong, Doric ^a   Ang, Chong Lye ^a,b  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; ASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LETTER; MALE; MYOPIA; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; AGED; ASIA; CHOROIDAL NEOVASCULARIZATION; ETHNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; VASCULARIZATION; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ASIA; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOPIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITREOUS BODY;

EID: 77954521485     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003;110:1297-305.
2. Ohno-Matsui K, Yoshida T. Myopic choroidal neovascularization: natural course and treatment. Curr Opin Ophthalmol 2004;15:197-202.
3. Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007;91:161-5.
4. Yamamoto I, Rogers HA, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularization secondary to pathologic myopia. Br J Ophthalmol 2007;91:157-60.
5. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-52.
6. Tzekov R, Lin T, Zhang KM, Jackson B, Oxejide A, Orilla W, et al. Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci 2006;47:377-85.